Drawing for CORVISION

USPTO serial 79286492

CORVISION

Reviewed by CopyMark Law Group

Reg. 6495490Status 700Renewal
Filing date
Status date
Registration date
Sep 28, 2021
Examiner
BILLINGS, JOHN T
Law office
PUBLICATION AND ISSUE SECTION

What this means

This registration is in, or will soon enter, a USPTO maintenance window. Missing a Section 8 or Section 9 filing can cancel the registration.

Status 700: Status 700 means the trademark is registered and active on the Principal Register. You have nationwide rights for the listed goods and services and may use ®. Section 8 maintenance is due between years five and six.

Need help with CORVISION?

If you own this trademark, we can monitor new filings and help with USPTO deadlines. If you do not, we can file a new U.S. application.

Current trademark owner
Get help with this Renewal, set up monitoring, or talk with CopyMark.
Get Attorney Assistance for just $548*

Plus Government fees of $650

Not the owner?
File a new U.S. trademark application, or speak with our attorneys.

Owner

Attorney of record

The USPTO lists this attorney as the applicant's representative for correspondence on this application.

R Peter Spies

R Peter Spies DTL Limited160 N Wacker DriveSuite 500Chicago, IL 60606

Goods and services

ClassDescriptionStatusFirst use
005Collagen for medical use; biological implants, namely, biological eye tissue intended for subsequent implantation, biological skin tissue intended for subsequent implantation, biological cardiac tissue intended for subsequent implantation, biological tissue grafts; biological corneal, cardiac, nerve, and skin tissue for implantation; surgical implants comprised of living tissues; biological materials in the nature of biological preparation for the treatment of eye disease for medical purposes; bioengineered materials in the nature of biological eye tissue; bioengineered biological organ tissues for medical, veterinary and pharmaceutical purposes; biological implants comprising biopolymers, namely, collagen, nanocellulose, and living tissue for delivery of stem cells and biological agents; implants comprising living tissue; implants comprising biopolymers, namely, collagen, nanocellulose for guided tissue regeneration; surgical implants biopolymers, namely, collagen, nanocellulose and native tissue, grown from stem cells; implantable materials in the nature of biopolymers, namely, collagen, nanocellulose, and native tissue for use in guided tissue regeneration; cell culture media for medical purposes for cultivating human and animal cells such as corneal, and cardiac cells and stem cellsACTIVE—
010Corneal implants in the form of inlays made of artificial and natural, non-living, materials; corneal microlens for sight correction being implants made of artificial and natural, non-living, materials; corneal shields being surgical implants and contact lenses made of artificial and natural, non-living, materials; corneal implants made of artificial and natural, non-living, materials; corneal implants for sight correction made of artificial and natural, non-living, materials; intra-corneal implants made of artificial and natural, non-living, materials; intra-ocular implants made of artificial and natural, non-living, materials; ocular implants made of artificial and natural, non-living, materials; medical implants made of artificial and natural, non-living, materials; biodegradable implants for eye, skin, and heart applications, made of artificial and natural, non-living, materials; prosthetic implants for eye, skin, and heart applications, made of artificial and natural, non-living, materials; artificial implants for eye, skin, and heart applications, made of artificial and natural, non-living, materials for delivery of cells, stem cells, drugs, genes, and proteinsACTIVE—

Related trademarks

CopyMark links this record to cited §2(d) serials, the owner's other marks, Nice classes, similar mark names, and recently changed USPTO applications.

Prosecution history

DateCodeEventWhat it means
Sep 28, 2026REM3COURTESY REMINDER - SEC. 71 (6-YR) E-MAILED—
Mar 7, 2025NREPNEW REPRESENTATIVE AT IB RECEIVED—
Apr 4, 2022FINOFINAL DECISION TRANSACTION PROCESSED BY IB—
Mar 15, 2022FICSFINAL DISPOSITION NOTICE SENT TO IB—
Mar 14, 2022FIMPFINAL DISPOSITION PROCESSED—
Dec 28, 2021FICRFINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB—
Sep 28, 2021R.PRREGISTERED-PRINCIPAL REGISTERYour trademark is registered on the Principal Register — the strongest form of federal trademark protection. You may use the ® symbol for the covered goods and services. Maintenance filings (Section 8 and renewals) are required to keep the registration alive.
Jul 13, 2021NPUBOFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED—
Jul 13, 2021PUBOPUBLISHED FOR OPPOSITIONYour mark was published in the USPTO Official Gazette for a 30-day opposition window. During that period, third parties who believe they would be harmed can file an opposition. If no opposition is filed, prosecution usually continues toward registration or a Notice of Allowance.
Jul 11, 2021GPNXNOTIFICATION PROCESSED BY IB—
Jun 23, 2021OPNSNOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB—
Jun 23, 2021OP2RNOTICE OF START OF OPPOSITION PERIOD CREATED, TO BE SENT TO IB—
Jun 23, 2021NONPNOTIFICATION OF NOTICE OF PUBLICATION E-MAILED—
Jun 4, 2021CNSAAPPROVED FOR PUB - PRINCIPAL REGISTER—
Jun 4, 2021XAECEXAMINER'S AMENDMENT ENTERED—
Jun 4, 2021GNENNOTIFICATION OF EXAMINERS AMENDMENT E-MAILED—
Jun 4, 2021GNEAEXAMINERS AMENDMENT E-MAILED—
Jun 4, 2021CNEAEXAMINERS AMENDMENT -WRITTEN—
Jan 9, 2021GNFNNOTIFICATION OF FINAL REFUSAL EMAILED—
Jan 9, 2021GNFRFINAL REFUSAL E-MAILEDA final Office Action (final refusal) means the examining attorney is maintaining at least one refusal and your options are narrower. You can file a response addressing the refusal, appeal to the Trademark Trial and Appeal Board, or let the application abandon.
Jan 9, 2021CNFRFINAL REFUSAL WRITTENA final Office Action (final refusal) means the examining attorney is maintaining at least one refusal and your options are narrower. You can file a response addressing the refusal, appeal to the Trademark Trial and Appeal Board, or let the application abandon.
Dec 19, 2020TEMETEAS/EMAIL CORRESPONDENCE ENTERED—
Dec 18, 2020CRFACORRESPONDENCE RECEIVED IN LAW OFFICE—
Dec 18, 2020TROATEAS RESPONSE TO OFFICE ACTION RECEIVEDThis event means the applicant filed a response to a USPTO Office Action — typically arguments, amendments, or evidence addressing the examiner's objections. The USPTO will review the response and either allow the mark to proceed or issue another action.
Dec 18, 2020CHANAPPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED—
Dec 18, 2020TCCATEAS CHANGE OF CORRESPONDENCE RECEIVED—
Dec 18, 2020ECDRTEAS CHANGE OF DOMESTIC REPRESENTATIVES ADDRESS—
Dec 18, 2020ARAAATTORNEY/DOM.REP.REVOKED AND/OR APPOINTEDThis event means the applicant filed a response to a USPTO Office Action — typically arguments, amendments, or evidence addressing the examiner's objections. The USPTO will review the response and either allow the mark to proceed or issue another action.
Dec 18, 2020REAPTEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED—
Dec 18, 2020COARTEAS CHANGE OF OWNER ADDRESS RECEIVED—
Aug 1, 2020RFNTREFUSAL PROCESSED BY IB—
Jul 14, 2020RFCSNON-FINAL ACTION MAILED - REFUSAL SENT TO IB—
Jul 14, 2020RFRRREFUSAL PROCESSED BY MPU—
Jun 9, 2020RFCRNON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW—
Jun 8, 2020CNRTNON-FINAL ACTION WRITTENA non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application.
Jun 2, 2020MAFRAPPLICATION FILING RECEIPT MAILED—
May 29, 2020DOCKASSIGNED TO EXAMINER—
May 29, 2020NWOSNEW APPLICATION OFFICE SUPPLIED DATA ENTERED—
May 28, 2020REPRSN ASSIGNED FOR SECT 66A APPL FROM IB—

Frequently asked questions

Related guidance